Assyro AI

FDA Orange Book · active-ingredient family

Misoprostol

Misoprostol is approved as 1 brand and 4 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:CYTOTEC · NDA 019268

1

Brand (NDA)

4

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · tablet

ProductApplicantApplicationTEApproved
CYTOTECRLD×2PFIZERNDA 019268ABSep 21, 1990

Generic (ANDA) products (4)

ProductApplicantApplicationTEApproved
MISOPROSTOL×2MICRO LABSANDA 216872ABOct 17, 2022
MISOPROSTOL×2ACQ PHARMAANDA 210201ABJul 02, 2019
MISOPROSTOL×2NOVEL LABS INCANDA 091667Jul 25, 2012
MISOPROSTOL×2ANI PHARMSANDA 076095ABJul 10, 2002

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Misoprostol — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.